Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.
Gross, Andrea M
Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies. [electronic resource] - American journal of medical genetics. Part A 04 2020 - 866-876 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
1552-4833
10.1002/ajmg.a.61485 doi
Biomarkers, Tumor--antagonists & inhibitors
Costello Syndrome--genetics
Ectodermal Dysplasia--genetics
Facies
Failure to Thrive--genetics
Heart Defects, Congenital--genetics
Humans
Intersectoral Collaboration
Molecular Targeted Therapy
Mutation
National Cancer Institute (U.S.)
Neurofibromatosis 1--genetics
Noonan Syndrome--genetics
Research Report
Signal Transduction
United States
ras Proteins--antagonists & inhibitors
Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies. [electronic resource] - American journal of medical genetics. Part A 04 2020 - 866-876 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
1552-4833
10.1002/ajmg.a.61485 doi
Biomarkers, Tumor--antagonists & inhibitors
Costello Syndrome--genetics
Ectodermal Dysplasia--genetics
Facies
Failure to Thrive--genetics
Heart Defects, Congenital--genetics
Humans
Intersectoral Collaboration
Molecular Targeted Therapy
Mutation
National Cancer Institute (U.S.)
Neurofibromatosis 1--genetics
Noonan Syndrome--genetics
Research Report
Signal Transduction
United States
ras Proteins--antagonists & inhibitors